Search results
Showing 6526 to 6540 of 8900 results
Discontinued Reference number: GID-TA11318
Discontinued Reference number: GID-TA11007
Discontinued Reference number: GID-TA10937
Empagliflozin for preventing cardiovascular events after acute myocardial infarction [ID6240]
In development Reference number: GID-TA11265 Expected publication date: TBC
In development Reference number: GID-TA11475 Expected publication date: TBC
Nivolumab with ipilimumab for untreated unresectable stage 3 non-small-cell lung cancer [ID6248]
In development Reference number: GID-TA11253 Expected publication date: TBC
In development Reference number: GID-TA11001 Expected publication date: TBC
Repotrectinib for treating ROS1-positive advanced non-small-cell lung cancer [ID6277]
In development Reference number: GID-TA11302 Expected publication date: TBC
In development Reference number: GID-TA11366 Expected publication date: TBC
In development Reference number: GID-TA11627 Expected publication date: TBC
In development Reference number: GID-TA11582 Expected publication date: TBC
Vimseltinib for treating tenosynovial giant cell tumours when surgery is unsuitable TSID 12099
In development Reference number: GID-TA11640 Expected publication date: TBC
Abicipar pegol for treating wet age-related macular degeneration [ID1533]
In development Reference number: GID-TA10511 Expected publication date: TBC
Discontinued Reference number: GID-NG10374